Filing Details
- Accession Number:
- 0001127602-10-031607
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-28 15:45:23
- Reporting Period:
- 2010-12-23
- Filing Date:
- 2010-12-28
- Accepted Time:
- 2010-12-28 15:45:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 850693 | Allergan Inc | AGN | Pharmaceutical Preparations (2834) | 951622442 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1051578 | I E David Pyott | 2525 Dupont Drive Irvine CA 92612 | Chairman And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-11-10 | 121,229 | $0.00 | 31,252 | No | 5 | G | Direct | |
| Common Stock | Acquisiton | 2010-11-10 | 121,229 | $0.00 | 242,458 | No | 5 | G | Indirect | By Living Trust |
| Common Stock | Disposition | 2010-12-23 | 37,029 | $70.15 | 205,429 | No | 4 | S | Indirect | By Living Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 5 | G | Indirect | By Living Trust |
| No | 4 | S | Indirect | By Living Trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,162 | Indirect | By 401(k) Trust |
| Common Stock | 2,872 | Indirect | By Esop Trust |
Footnotes
- Transfer of 121,229 shares held directly by the reporting person to the David and Julianna Pyott Living Trust.
- David and Julianna Pyott Living Trust dated June 14, 1999, in which the reporting person has a pecuniary interest and of which the reporting person and his spouse are each trustees.
- The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 11, 2010.
- The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.49, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities Exchange Commission, upon request, the full information regarding the number of shares sold at each price within the range set forth in this footnote.
- Shares allocated to reporting person's SIP account as of reporting date.
- Shares allocated to the reporting person's ESOP account as of reporting date.
Billionaire Hedge Funds
